Revvity to announce Q2 2026 results on August 4
Revvity will release its Q2 2026 financial results on August 4, 2026, before market open, followed by a conference call at 7:30 a.m. ET hosted by CEO Prahlad Singh and CFO Max Krakowiak. The company reported 2025 revenue of $2.9 billion and serves customers in over 160 countries.

*this image is generated using AI for illustrative purposes only.
Revvity will release its second quarter 2026 financial results before market open on Tuesday, August 4, 2026. The company will host a conference call the same day at 7:30 a.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Max Krakowiak, chief financial officer, will host the conference call.
Investors can access the live audio webcast through the Investors section of Revvity's website. The company provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure.
Company Overview
Revvity reported 2025 revenue of $2.9 billion and employs approximately 11,000 people. The company serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments in more than 160 countries. It is part of the S&P 500 index.
Key Details
| Event | Date/Time |
|---|---|
| Q2 2026 Results Release | Tuesday, August 4, 2026 (before market open) |
| Conference Call | Tuesday, August 4, 2026 at 7:30 a.m. ET |
| Hosts | Prahlad Singh (President and CEO), Max Krakowiak (CFO) |
What strategic initiatives will Revvity prioritize in the second half of 2026 to drive growth?
How might Revvity's performance in Q2 2026 impact its position within the S&P 500?
What are the expected market reactions to Revvity's Q2 2026 financial results?
























